wuji 2013-09-06 11:20
药用空心胶囊产品检验环节,在“检验机”中混色胶囊无法惕除。透明胶囊外观缺陷无法检验。 预期目标:解决产品质量检验难题。 合作方式:公司可提供20-50万元资金共同研制开发此技术。 该检验技术目前可适用于混色和不透明的胶囊产品检验。   [更多]
悬赏:
悬赏
¥0.00
载入中...
changxin 2012-11-02 11:57
PXE国际关于弹性假黄瘤(PXE)的研究团队,对其的病因提出了现有的两种假设:积极的循环代谢产物或者组织特异性功能障碍。任务要求提供数据来求证这两种假设或其中之一。根据各地的发病机制进行实验,进一步了解PXE的病因。 这项任务保证至少会奖励一名挑战者,并且,除了任务奖金之外,PXE国际还将对中标者给予PXE的研究经费资助。 征稿件请直接上传网址:https://www.innocentive.com PXE – Evaluating Hypotheses and Suggesting Experiments for a Rare Disease TAGS: Computer Science/Information Technology, Chemistry, Global Health, Nature, Public Good, Life Sciences, Ideation AWARD: $7,000 USD | DEADLINE: 11/30/12 | ACTIVE SOLVERS: 38 | POSTED: 10/31/12 The Seeker, PXE International, the primary group responsible for funding PXE research, presents two existing hypotheses (an active circulating metabolite(s) or a tissue-specific dysfunction) for the rare disease Pseudoxanthoma Elasticum (PXE). The Seeker requests that Solvers present evidence favoring one of the two hypotheses, then provide additional experiments to conduct to further knowledge around the disease mechanism. This is an Ideation Challenge with a guaranteed award for at least one submitted solution. In addition to the Challenge award, PXE International will also assist finalists in efforts to obtain funding for PXE-related research. Detailed Description & Requirements INTRODUCTION TO PXE Pseudoxanthoma Elasticum (PXE) is a recessive genetic disorder with signs and symptoms that mimic many aspects of the normal aging process, but at a much younger age (when people are roughly between 10 and 20 years old). Specifically, the disease is characterized by fragmentation and mineralization of elastic fibers in certain tissues. Some of the more common symptoms, in general order that they occur, are: Wet-type macular degeneration Skin wrinkling Calcification of blood vessels Cardiovascular disease PXE is a rare disease with an estimated patient population of 12,000 people. Given the small number of people with the disease, it has not been the subject of research by for-profit pharmaceutical and biotech companies.   [更多]
悬赏:
悬赏
¥0.00
载入中...
wuji 2013-12-20 10:19
寻求临床微生物快速鉴定及药敏快速测定,请有这方面测定技术的与我联系   [更多]
悬赏:
悬赏
¥0.00
载入中...
njruich 2012-11-20 17:22
需要意大利药典标准的匹多莫德口服溶液的标准,不是欧洲药典的,如果有请报价   [更多]
悬赏:
悬赏
¥0.00
载入中...
nigreat 2012-11-23 13:55
维生素EC咀嚼片(北京四环科宝)检验记录, 北京市药检所检验,05-06年检验,药厂检验记录也行, 北京四环科宝制药有限公司 受理号:CXHS0501762京 注意一下,要的是检验记录而不是检验报告,主要是想获得药品的片重,因为目前市场上这个品种没有销售 联系qq号:393987918   [更多]
悬赏:
悬赏
¥0.00
载入中...
csc 2012-05-10 10:51
目前公司金银花绿原酸粗提产品总灰分超标,高达15%---20%。原材料灰分符合国家药典标准,在10%以内,但提取,过滤,纳滤浓缩,复浓缩之后,滤袋过滤,喷雾干燥,得到的产品总灰分高达18%,有的高过20%,我们生产过程中用的水都是RO反渗透纯化水。 希望有关专家现场指导或合作开发处理   [更多]
悬赏:
悬赏
¥0.00
载入中...
changxin 2012-12-25 15:03
这个任务要求提供一种测试方法,能够简单的检测出血友病A 中凝血因子Ⅷ和血友病B 中凝血因子IX在血液中的水平。因为现在市面上所使用的测试方法都不太方便,都不适用于诊所,而且患者也不能在家里进行自我检测。这个任务要求提供一个半定量的测试方式,需要提供可靠的血液中凝血因子水平的资料,然后根据情况分为正常,轻微,严重三种疾病状态。   “征稿件请直接上传网址:https://www.innocentive.com”   TAGS: Engineering/Design, Chemistry, Global Health, Nature, Life Sciences, Food/Agriculture, Theoretical-IP Transfer   AWARD: $25,000 USD | DEADLINE: 2/21/13 | ACTIVE SOLVERS: 27 | POSTED: 12/21/12   The Seeker requires a test that could easily be used to monitor the level of blood coagulation factors FVIII or FIX present in hemophilia A and B patients, respectively. Today, many tests are commercially available, but none are suited for convenient testing either by care providers in the clinic or by hemophilia patients at home. A semi-quantitative test is required that would provide reliable information on the blood levels of FVIII or FIX relative to a state considered as ‘Normal’, ‘Mild’ or ‘Severe’ state of disease.   This Challenge requires only a written proposal.   Detailed Description & Requirements   Background   Hemophilia A and B are inherited coagulation diseases that severely impact the quality of life of persons afflicted. Hemophilia A is caused by lack of coagulation factor VIII (FVIII), while in hemophilia B patients lack coagulation factor IX (FIX). Although the diseases are to a large extent manageable using clotting factor supplement therapies, FVIII and FIX treatment needs to be monitored in order to ensure that it meets the requirements of the individual patients’ plasma level of the coagulations factor to be supplemented. Current tests require tedious laboratory analysis, not allowing patients to achieve the frequency of testing that would facilitate good management of their disease.   The Problem   Hemophilia patients are expected to benefit from daily monitoring of their disease status (i.e. measurements of FVIII or FIX levels) to check the efficacy of their therapy and the current status of their disease.   [更多]
悬赏:
悬赏
¥0.00
载入中...
gonggong 2013-07-26 11:49
海洋生物医药的开发新技术。目前我国海洋生物医药的开发程度还不高,但国家对这一领域的重视程度在不断加深。海洋规划已经提到,要发展海洋生物产品精深开发的理论、技术与装备。寻求重点开发基于功能基因、功能酶和活性物质等功效因子的生物材料和生物制品;研究海洋药物的成药机理和开发技术,开展细菌等微生物和微藻的开发利用。海洋生物医药、新型海洋生物制品以及新型海洋生物材料都将成为我们重点研究方向   [更多]
悬赏:
悬赏
¥0.00
载入中...
wuji 2013-10-15 11:12
灵芝子实体为木质素,材质较坚硬,按传统的提取方法是:醇提、水提和酶解水提。但醇提成本高,花工大,一般很少使用;水提工效低,而且还有些灵芝成分未充分提取,技术有待改进;酶解水提时间长,一般要先经10~15h的酶解,再结合水提,时间长、工效低。要用何种方法能促使灵芝组织松动,便于提取,而所提取的灵芝有效成分得到充分利用。   [更多]
悬赏:
悬赏
¥0.00
载入中...
发布需求,坐等药智客上门
  • 安全可靠,先验收再正式付款
  • 性价比超高,节省一半费用
  • 80%的需求得到了圆满解决
立即发布需求

推荐任务